ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag federal microbiology

Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Alfred Pühler
Cormac Sheridan | Jan 12, 2009 | 3 min read
Alfred Pühler Forty years (and counting) at the forefront of microbiology research have not dimmed Pühler's infectious enthusiasm or voracious work ethic. By Cormac Sheridan Alfred Pühler has been a powerhouse in German microbiological research—initially in the area of plant-microbe interactions and later in industrial microbiology—over the past four decades. But he actually started out in nuclear physics, obtain
Monitoring Mutations with Microfluidics
Ruth Williams | Mar 15, 2018 | 3 min read
A device dubbed the “mother machine” enables real-time observation of mutagenesis in single bacterial cells.  
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Observers Praise AIDS Report But Foresee Problems In Implementation
Steven Benowitz | May 12, 1996 | 10 min read
Problems In Implementation LOUD AND CLEAR: Attorney Lynda Dee stresses the need for communication among the institutes. When a federally appointed panel announced in March the results of its 15-month-long review of the United States government's AIDS research program, AIDS activists as well as scientists cheered. The National Institutes of Health's AIDS Research Program Evaluation Working Group's recommendations largely called for scrapping what the group saw as outdated and ineffective polic
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
AIDS Investigators Cautiously Applauding Recent Advances
Steven Benowitz | Sep 29, 1996 | 10+ min read
Discoveries announced at conference leave scientists feeling optimistic; yet their enthusiasm is tempered by several persistent concerns. AIDS researchers have many reasons to be encouraged. Studies show that treatments combining new and old drugs can control HIV levels in the blood. Moreover, many scientists and activists note, prevention efforts have helped reduce HIV infection rates. Yet the enthusiasm is tempered by several caveats. Drugs are expensive and have harsh side effects, leading
Mircens Help Bring First-Rate Science To The Third World
Robin Eisner | Sep 1, 1991 | 9 min read
Microbiologist J.K. Arap Keter is betting that some recently collected strains of the bacterial genus Rhizobium will soon join the family of other nonpolluting, inexpensive, microbial biofertilizers currently in use by thousands of East African farmers on legume crops. But first he and colleagues in the department of soil science at the University of Nairobi in Kenya must show that the new isolates can foster different plants' growth by helping the plants use nitrogen. After that, they must cu
An 'Iterative Process'
Billy Goodman | Jul 9, 1995 | 7 min read
Sidebar: The AIDS Research Evaluators The 100-plus members of a newly constituted National Institutes of Health task force have begun their daunting task: a comprehensive reevaluation of NIH's entire $1.4 billion AIDS portfolio, including both intramural and extramural research. Compounding the challenge for the scientists and AIDS activists who make up the task force is a withering schedule. They will have to produce a report due in January 1996, to aid in planning the 1998 Office of AIDS Rese

Run a Search

ADVERTISEMENT